Somatropin (Critical)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSomatropin (Critical)
Drug Alias NameCP 024Somatropin intranasal-Critical PharmaceuticalsSomatropin intranasal (Critical Pharmaceuticals)CP024CP-024
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCritical Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCritical Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsGrowth hormone deficiency

Other Information

ATC CodeN/A
Related LinksN/A